{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:24:27Z","timestamp":1780392267704,"version":"3.54.1"},"reference-count":37,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Trevena, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2022,5,19]]},"DOI":"10.1080\/14737167.2022.2038137","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T12:20:09Z","timestamp":1644236409000},"page":"671-681","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events"],"prefix":"10.1080","volume":"22","author":[{"given":"Kit N","family":"Simpson","sequence":"first","affiliation":[{"name":"Department of Healthcare Leadership & Cedar Core (Comparative Effectiveness Data Analytics Resources), Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Fossler","sequence":"additional","affiliation":[{"name":"Clinical Development and Quantitative Biosciences, Trevena, Inc., Chesterbrook, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wase","sequence":"additional","affiliation":[{"name":"Medical Affairs, Trevena, Inc., Chesterbrook, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Demitrack","sequence":"additional","affiliation":[{"name":"Medical Affairs, Trevena, Inc., Chesterbrook, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd L","family":"Wandstrat","sequence":"additional","affiliation":[{"name":"Health Economics and Medical Sciences, Trevena, Inc., Chesterbrook, Chesterbrook, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1351138"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-018-0106-9"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11477"},{"key":"cit0004","first-page":"S276","volume":"17","author":"Overholser BR","year":"2011","journal-title":"Am J Manag Care"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.1039"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1177\/2151458510394606"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12049"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2021-0107"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S171013"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12801"},{"key":"cit0011","unstructured":"US Food & Drug Administration. FDA approves new opioid for intravenous use in hospitals, other controlled clinical settings [media release]. August 26, 2020. [cited 2021 July 22]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-opioid-intravenous-use-hospitals-other-controlled-clinical-settings"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201616"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5449.2495"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.087254"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S217563"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.02.002"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.21037\/dmr.2019.08.07"},{"key":"cit0018","unstructured":"US Department of Health and Human ServicesMorrison B, Kelliher L, and Jones C. Agency for Healthcare Research and Quality (AHRQ). The Healthcare Cost and Utilization Project (HCUP), National (Nationwide) Inpatient Sample (NIS) dataset. [cited 2021 July 22]. https:\/\/hcupnet.ahrq.gov\/"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004788"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1080\/15360288.2019.1668902"},{"key":"cit0021","first-page":"3215923","author":"Rao VK","year":"2018","journal-title":"Anesthiol Res Pract"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-021-01307-8"},{"key":"cit0023","volume-title":"Anesthesiology 2019 Meeting","author":"Saager L","year":"2019"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200004000-00012"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2015.01.006"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2020.56.4.3107707"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S183404"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000792"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003143"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2020.04.001"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003428"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003725"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003705"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.152"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00936-0"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00216-x"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/S1553-7250(12)38016-1"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2022.2038137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T18:36:21Z","timestamp":1655231781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2022.2038137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5,19]]}},"alternative-id":["10.1080\/14737167.2022.2038137"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2022.2038137","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}